General Information of Disease (ID: DIST91OT)

Disease Name Pure red-cell aplasia
Synonyms red cell hypoplasia; pure red cell aplasia; primary red cell aplasia; Pure Red Cell Aplasia, Acquired; PRCA
Definition A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia, and selective erythroid hypoplasia.
Disease Hierarchy
DISI8W45: Anaemia
DIST91OT: Pure red-cell aplasia
Disease Identifiers
MONDO ID
MONDO_0001705
MESH ID
D012010
UMLS CUI
C0034902
MedGen ID
11154
HPO ID
HP:0012410
SNOMED CT ID
50715003

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
SULF2 TTLQTHB Limited Genetic Variation [1]
FANCF TTNZKFJ moderate Genetic Variation [2]
RNASEL TT7V0K4 moderate Genetic Variation [3]
TEC TT1ZV49 moderate Biomarker [4]
HAMP TTRV5YJ Strong Biomarker [5]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ABO DESIA7R Strong Biomarker [6]
------------------------------------------------------------------------------------
This Disease Is Related to 8 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
LRP1B OT4YZG2N moderate Genetic Variation [2]
RO60 OTLGM5A8 moderate Biomarker [7]
RPS17 OTWHZ2JQ moderate Biomarker [8]
RPS24 OTSNKIL5 moderate Biomarker [8]
CBX4 OT4XVRRF Strong Genetic Variation [9]
ELAC2 OTY3BOF6 Strong Genetic Variation [9]
RPS19 OTBKGP48 Strong Biomarker [10]
PALB2 OT6DNDBG Definitive Biomarker [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DOT(s)

References

1 Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.Hum Hered. 2011;72(3):182-93. doi: 10.1159/000331222. Epub 2011 Nov 11.
2 Identification of mutations in patients with acquired pure red cell aplasia.Acta Biochim Biophys Sin (Shanghai). 2018 Jul 1;50(7):685-692. doi: 10.1093/abbs/gmy052.
3 Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.Am J Hum Genet. 2002 May;70(5):1299-304. doi: 10.1086/340450. Epub 2002 Apr 8.
4 Transient Erythroblastopenia of Childhood: A Review for the Pediatric Emergency Medicine Physician.Pediatr Emerg Care. 2019 Mar;35(3):237-240. doi: 10.1097/PEC.0000000000001760.
5 Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia.Biomed Res Int. 2014;2014:421304. doi: 10.1155/2014/421304. Epub 2014 Dec 18.
6 Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab.Eur J Haematol. 2020 Feb;104(2):145-147. doi: 10.1111/ejh.13343. Epub 2019 Nov 20.
7 Lupus enteritis during pregnancy: A case-based review.Mod Rheumatol. 2017 Nov;27(6):1089-1092. doi: 10.3109/14397595.2015.1055642. Epub 2015 Aug 18.
8 A new database for ribosomal protein genes which are mutated in Diamond-Blackfan Anemia.Hum Mutat. 2008 Nov;29(11):E263-70. doi: 10.1002/humu.20864.
9 ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.Cancer Res. 2001 Aug 15;61(16):6038-41.
10 A Novel Deletion in the RPL5 Gene in a Lebanese Child With Diamond Blackfan Anemia Unresponsive to Steroid Treatment.J Pediatr Hematol Oncol. 2020 May;42(4):e235-e237. doi: 10.1097/MPH.0000000000001435.
11 Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.Prostate. 2008 May 1;68(6):675-8. doi: 10.1002/pros.20729.